FPT Software has been named a Major Player in the IDC MarketScape: Asia/Pacific Managed Security Services (MSS) 2024 Vendor Assessment (Doc # AP51571224, Septemb......
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat bra......